Found: 286
Select item for more details and to access through your institution.
Cell kinetics in acute leukemia: a critical reevaluation based on new data.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
- Published in:
- 1995
- By:
- Publication type:
- journal article
DNA and RNA flow cytometric study in multiple myeloma. Clinical correlations.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 2, p. 203, doi. 10.1007/s12185-024-03787-z
- By:
- Publication type:
- Article
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML).
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 1023, doi. 10.1007/s10637-013-9935-x
- By:
- Publication type:
- Article
Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 6, p. 1696, doi. 10.1002/jcb.23090
- By:
- Publication type:
- Article
Phase 1 study of combinatorial sorafenib, G‐CSF, and plerixafor treatment in relapsed/refractory, FLT3‐ITD‐mutated acute myelogenous leukemia patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1296, doi. 10.1002/ajh.25943
- By:
- Publication type:
- Article
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 984, doi. 10.1002/ajh.25553
- By:
- Publication type:
- Article
A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 74, doi. 10.1002/ajh.25318
- By:
- Publication type:
- Article
Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1245, doi. 10.1002/ajh.25234
- By:
- Publication type:
- Article
Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1136, doi. 10.1002/ajh.25198
- By:
- Publication type:
- Article
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 331, doi. 10.1002/ajh.24632
- By:
- Publication type:
- Article
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 7, doi. 10.1002/ajh.24568
- By:
- Publication type:
- Article
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1221, doi. 10.1002/ajh.24500
- By:
- Publication type:
- Article
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 800, doi. 10.1002/ajh.24415
- By:
- Publication type:
- Article
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1065, doi. 10.1002/ajh.24140
- By:
- Publication type:
- Article
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 276, doi. 10.1002/ajh.23924
- By:
- Publication type:
- Article
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. 961, doi. 10.1002/ajh.23544
- By:
- Publication type:
- Article
Nachweis von minimaler Resterkrankung bei Patienten mit akuter myeloischer Leukämie und myelodysplastischem Syndrom in klinischer Remission mittels molekularer Zytogenetik.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 1997, v. 21, n. 11, p. 613
- By:
- Publication type:
- Article
Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1128, doi. 10.3390/cells12081128
- By:
- Publication type:
- Article
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.880108
- By:
- Publication type:
- Article
Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents.
- Published in:
- Oncogene, 1998, v. 16, n. 12, p. 1587, doi. 10.1038/sj.onc.1201681
- By:
- Publication type:
- Article
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41229-2
- By:
- Publication type:
- Article
Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 6, p. 1, doi. 10.1038/s41419-023-05844-7
- By:
- Publication type:
- Article
A TRIBUTE TO THE HONORABLE SAM H. BELL ('52).
- Published in:
- 2012
- By:
- Publication type:
- Obituary
Effect of Door-Locking Policy on Inpatient Treatment of Substance Use and Dual Disorders.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-35198-6
- By:
- Publication type:
- Article
Early detection of transformation to BPDCN in a patient with MDS.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0117-6
- By:
- Publication type:
- Article
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01538
- By:
- Publication type:
- Article
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00991
- By:
- Publication type:
- Article
Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
- Published in:
- Oncogene, 2012, v. 31, n. 23, p. 2849, doi. 10.1038/onc.2011.462
- By:
- Publication type:
- Article
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
- Published in:
- Oncogene, 2012, v. 31, n. 1, p. 68, doi. 10.1038/onc.2011.213
- By:
- Publication type:
- Article
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.
- Published in:
- Gene Therapy, 2008, v. 15, n. 10, p. 730, doi. 10.1038/gt.2008.39
- By:
- Publication type:
- Article
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 355, p. 1, doi. 10.1126/scitranslmed.aag1180
- By:
- Publication type:
- Article
Class IA Phosphatidylinositol 3-Kinase Inhibition Inhibits Cell Growth and Proliferation in Mantle Cell Lymphoma.
- Published in:
- Acta Haematologica, 2013, v. 131, n. 1, p. 59, doi. 10.1159/000353164
- By:
- Publication type:
- Article
Phase I Study of Taxol in Refractory Acute Myelogenous Leukemias Using a Weekly Schedule.
- Published in:
- Acta Haematologica, 1998, v. 99, n. 2, p. 106, doi. 10.1159/000040822
- By:
- Publication type:
- Article
Implications of 'Cell Kill' for the Treatment of Acute Myelogenous Leukemia: Can the Cure Rate Be Increased?
- Published in:
- Acta Haematologica, 1989, v. 82, n. 4, p. 175, doi. 10.1159/000205372
- By:
- Publication type:
- Article
Prevalence of Hyperglycemia and Obesity in Patients (pts) with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).
- Published in:
- Diabetes, 2007, v. 56, p. A274
- By:
- Publication type:
- Article
Polysomy of chromosome 12 in 60 patients with non-hodgkin's lymphoma assessed by fluorescence in situ hybridization: Differences between follicular and diffuse large cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 1994, v. 9, n. 3, p. 161, doi. 10.1002/gcc.2870090303
- By:
- Publication type:
- Article
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2001, v. 67, n. 4, p. 227, doi. 10.1002/ajh.1121
- By:
- Publication type:
- Article
Childhood CML in blastic stage: An analysis of cell markers and cell kinetics.
- Published in:
- American Journal of Hematology, 1980, v. 9, n. 3, p. 337, doi. 10.1002/ajh.2830090313
- By:
- Publication type:
- Article
Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 3, p. 184, doi. 10.1093/jnci/djm328
- By:
- Publication type:
- Article
Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 15, p. 1068, doi. 10.1093/jnci/djj300
- By:
- Publication type:
- Article
RESPONSE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 7, p. 541, doi. 10.1093/jnci/dji089
- By:
- Publication type:
- Article
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 21, p. 1593, doi. 10.1093/jnci/djh299
- By:
- Publication type:
- Article
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
- Published in:
- Oncogene, 2007, v. 26, n. 28, p. 4148, doi. 10.1038/sj.onc.1210186
- By:
- Publication type:
- Article
Differential tumor suppressor properties and transforming growth factor-β responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation.
- Published in:
- Oncogene, 2007, v. 26, n. 10, p. 1439, doi. 10.1038/sj.onc.1209907
- By:
- Publication type:
- Article
Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
- Published in:
- Oncogene, 2006, v. 25, n. 32, p. 4483, doi. 10.1038/sj.onc.1209477
- By:
- Publication type:
- Article